Previous 10 | Next 10 |
DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care PR Newswire Kidney care provider harnesses the power of Google Cloud's leading-edge infrastructure, AI, and analytics tools to help improve care plans and st...
DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call PR Newswire DENVER , Oct. 17, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, Nove...
2023-10-17 15:23:07 ET Summary Healthcare providers are undervalued by about 9% relative to 11-year averages. Healthcare equipment is the most overvalued subsector. Fast facts on iShares U.S. Healthcare Providers ETF, a healthcare providers fund. 10 stocks cheaper than the...
2023-10-13 08:00:00 ET Summary Investors are pulling out of the stock market and into lower-yielding investments like T-bills, causing stock prices to drop. REITs, such as Agree Realty and Realty Income, have seen their prices decline, presenting an opportunity for investors. ...
2023-10-12 15:39:22 ET More on Fresenius Medical Care Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2023 Earnings Call Transcript Fresenius Medical Care: Heads Don't Roll - They Run ...
2023-10-12 13:24:12 ET More on Baxter, DaVita, etc. Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial? Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be...
2023-10-12 10:54:14 ET Summary Novo Nordisk ended its kidney outcome trial early after interim results showed the efficacy of its drug-Ozempic in delaying the progression of chronic kidney disease. Stocks of medical equipment major, Baxter International, and kidney care servicing ...
DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease PR Newswire DENVER , Oct. 12, 2023 /PRNewswire/ -- DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like...
2023-10-11 14:51:11 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita stock sell-off over Ozempic study 'big overreaction,' says UBS DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold ...
2023-10-11 12:51:59 ET Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease. Dialysis products and services providers were broadly negative in early...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...